|
10 Jul 2025 |
CreditAccess Grameen
|
Consensus Share Price Target
|
1290.80 |
1236.56 |
- |
-4.20 |
buy
|
|
|
|
|
23 Jun 2025
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1290.80
|
1310.00
|
1126.60
(14.57%)
|
Target met |
Accumulate
|
|
|
declined by 10 bps compared to FY24, settling at 12.9%. Operating expenses increased by 11.0% YoY to Rs.1,108 cr. in FY25, while a decline in fee and other income led to a marginal rise in the cost-to-income ratio to 30.7%, up from 30.5% in the previous year. Despite a sharp 327.1% YoY increase in provisions due to accelerated write-offs targeting delinquent accounts, the company reported an annual profit of Rs.531.4 cr. Gross NPA and Net NPA rose sharply to 4.8% and 1.7%, respectively, from 1.2% and 0.4% in FY24, reflecting a notable deterioration across all PAR buckets. While collection efficiency remained subdued for the first three quarters of the year, it showed signs of recovery towards the end of FY25, indicating early momentum in asset quality stabilization....
|
|
17 May 2025
|
CreditAccess Grameen
|
Motilal Oswal
|
1290.80
|
1425.00
|
1204.70
(7.15%)
|
10.40 |
Buy
|
|
|
CreditAccess Grameen’s (CREDAG) 4QFY25 PAT stood at INR472m (est. INR698m). FY25 PAT declined ~63% YoY to INR5.3b. 4Q NII was flat YoY at ~INR8.8b (in line). PPOP declined ~7% YoY to INR6.3b (~7% miss).
|
|
19 Mar 2025
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1290.80
|
1130.00
|
943.80
(36.77%)
|
Target met |
Buy
|
|
|
|
|
27 Jan 2025
|
CreditAccess Grameen
|
Axis Direct
|
1290.80
|
975.00
|
923.80
(39.73%)
|
Target met |
Hold
|
|
|
We revise our rating from BUY to HOLD.
|
|
26 Jan 2025
|
CreditAccess Grameen
|
Motilal Oswal
|
1290.80
|
1070.00
|
916.60
(40.82%)
|
Target met |
Buy
|
|
|
CreditAccess Grameen (CREDAG)’s 3QFY25 loss stood at INR995m (vs. MOFSLe PAT of INR1.3b). NII grew ~7% YoY to ~INR8.6b (~6% miss) and PPoP rose 4% YoY to ~INR6.2b (~6% miss). Cost-income ratio was stable at ~31% (PY: ~30% and PQ: ~31%).
|
|
26 Jan 2025
|
CreditAccess Grameen
|
Edelweiss
|
1290.80
|
|
916.60
(40.82%)
|
|
Not Rated
|
|
|
Stress in MFI intensifies pressure on credit growth and asset quality
|
|
19 Nov 2024
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1290.80
|
976.00
|
884.60
(45.92%)
|
Target met |
Accumulate
|
|
|
|
|
28 Oct 2024
|
CreditAccess Grameen
|
Axis Direct
|
1290.80
|
1100.00
|
957.45
(34.82%)
|
Target met |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
27 Oct 2024
|
CreditAccess Grameen
|
Motilal Oswal
|
1290.80
|
1155.00
|
981.50
(31.51%)
|
Target met |
Buy
|
|
|
CreditAccess Grameen (CREDAG)’s 2QFY25 PAT declined ~46% YoY to ~INR1.86b (~29% miss). 1HFY25 PAT declined ~16% YoY to ~INR5.8b, and we expect 2HFY25 PAT to decline ~38% YoY.
|
|
31 Jul 2024
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1290.80
|
1565.00
|
1327.65
(-2.78%)
|
21.24 |
Buy
|
|
|
|
|
26 Jul 2024
|
CreditAccess Grameen
|
ICICI Direct
|
1290.80
|
1650.00
|
1311.95
(-1.61%)
|
27.83 |
Buy
|
|
|
|
|
22 Jul 2024
|
CreditAccess Grameen
|
Axis Direct
|
1290.80
|
1700.00
|
1267.15
(1.87%)
|
31.70 |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
21 Jul 2024
|
CreditAccess Grameen
|
Edelweiss
|
1290.80
|
1610.00
|
1284.50
(0.49%)
|
24.73 |
Buy
|
|
|
Maintains guidance despite asset quality pressures
|
|
20 Jul 2024
|
CreditAccess Grameen
|
ICICI Securities Limited
|
1290.80
|
1950.00
|
1284.50
(0.49%)
|
51.07 |
Buy
|
|
|
CA Grameen’s business resiliency reflects in only 50bps drop in collections to 97.8% during Q1FY25 vs 98.3% in Q4FY25 and best-in-class return ratios with RoA at >5% and RoE at >20% for the sixth consecutive quarter.
|
|
24 May 2024
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1290.80
|
1628.00
|
1394.75
(-7.45%)
|
|
Buy
|
|
|
|
|
08 May 2024
|
CreditAccess Grameen
|
ICICI Direct
|
1290.80
|
1800.00
|
1428.65
(-9.65%)
|
|
Buy
|
|
|
|
|
08 May 2024
|
CreditAccess Grameen
|
Axis Direct
|
1290.80
|
1900.00
|
1428.65
(-9.65%)
|
|
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
08 May 2024
|
CreditAccess Grameen
|
Edelweiss
|
1290.80
|
1800.00
|
1428.65
(-9.65%)
|
|
Buy
|
|
|
Beat on operating metrics; maintained guidance
|
|
08 May 2024
|
CreditAccess Grameen
|
Motilal Oswal
|
1290.80
|
1725.00
|
1428.65
(-9.65%)
|
|
Buy
|
|
|
CreditAccess Grameen (CREDAG) delivered a healthy operational performance in 4QFY24, with 34% YoY growth in PAT to ~INR3.97b (inline). 4QFY24 NII grew ~42% YoY to ~INR8.8b and PPoP grew 36% YoY to ~INR6.8b. FY24 PAT grew ~31% YoY to ~INR5.1b.
|
|
08 May 2024
|
CreditAccess Grameen
|
Emkay
|
1290.80
|
2000.00
|
1428.65
(-9.65%)
|
|
Buy
|
|
|
CredAG continues to report strong GLP growth at 32% YoY/14% QoQ. This, coupled with stable margins and higher other income and partially offset by higher LLP and staff costs (due to one-off provision of Rs260mn towards bonus and ex-gratia), led to an almost in-line PAT at Rs4bn/RoA @5.7% (Emkay PAT: Rs3.9bn).
|